EX-FILING FEES 2 nvax-20220808xs8xex1071.htm EX-FILING FEES Document

Exhibit 107.1
Calculation of Filing Fee Tables

Form S-8
(Form Type)

Novavax, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities
Security TypeSecurity
Class
Title
Fee
Calculation
Rule
Amount
Registered
(1)
Proposed
Maximum
Offering Price
Per Unit
(2)

Maximum
Aggregate
Offering Price(2)
Fee RateAmount of
Registration Fee
Equity
Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan - Common Stock, par value $0.01 per share457(c) and 457(h)550,000$54.55$30,002,5000.0000927$2,781.24
Equity
Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan - Common Stock, par value $0.01 per share457(c) and 457(h)2,400,000$54.55$130,920,0000.0000927$12,136.29
Total Offering Amounts$160,922,500$14,917.53
Total Fee Offsets
Net Fee Due$14,917.53

(1)

 
Pursuant to Rule 416(a) promulgated under the Securities Act, this Registration Statement also covers such additional shares of the Registrant’s Common Stock as may be issued to prevent dilution from stock splits, stock dividends and similar transactions.
(2)
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and 457(h) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based upon the average of the high and low sale price of the Registrant’s Common Stock, as reported by the Nasdaq Global Select Market on August 1, 2022, which were $56.28 and $52.81, respectively.